A randomised phase III study on capecitabine, oxaliplatin and bevacizumab with or without cetuximab in first-line advanced colorectal cancer, the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG). An interim analysis of toxicity

Verfasser: Tol, J.
Koopman, M.
Rodenburg, C.J.
Cats, A.
Creemers, G.J.
Schrama, J.G.
Erdkamp, F.L.G.
Vos, A.H.
Mol, L.
Antonini, N.F.
Punt, C.J.A.
Dokumenttyp: Artikel
Erscheinungsdatum: 2008
Reihe/Periodikum: Annals of Oncology ; volume 19, issue 4, page 734-738 ; ISSN 0923-7534
Verlag/Hrsg.: Elsevier BV
Schlagwörter: Oncology / Hematology
Sprache: Englisch
Permalink: https://search.fid-benelux.de/Record/base-27415921
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : http://dx.doi.org/10.1093/annonc/mdm607